Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease
Davide Capodanno, Deepak L. Bhatt, John W. Eikelboom, Keith A.A. Fox, Tobias Geisler, C. Michael Gibson, José Ramón González‐Juanatey, Stefan James, Renato D. Lópes, Roxana Mehran, Gilles Montalescot, Manesh R. Patel, Philippe Gabríel Steg, Robert F. Storey, Pascal Vranckx, Jeffrey I. Weitz, Robert C. Welsh, Uwe Zeymer, Dominick J. Angiolillo
Topics & Concepts
MedicineAntithromboticDiseaseCoronary artery diseaseAntiplatelet drugVitamin K antagonistCilostazolIntensive care medicineInternal medicineCardiologyMyocardial infarctionAspirinClopidogrelWarfarinAtrial fibrillationAntiplatelet Therapy and Cardiovascular DiseasesAtrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management